(6.1) The most common adverse reactions (incidence 20%) of pemetrexed when administered in combination with pembrolizumab and platinum chemotherapy are fatigue/asthenia, nausea, constipation, diarrhea, decreased appetite, rash, vomiting, cough, dyspnea, and pyrexia
The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day
These vitamins decrease the chances of anaemia and promote good cardiovascular health
PMID 24470095
Contrarily, generally no new vessels grew in BPC 157treated rats (i.e., those that did form in the limbus did not make contact with the penetrated area) (Masnec et al., 2015), showing that BPC 157 therapy may acknowledge also the angiogenic privilege of the corneal avascularity as essential for corneal wound healing (Tshionyi et al., 2012)